MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Early morning OFF problems are common in PD patients attending a routine clinical appointment

    F. Stocchi, C. Coletti, S. Bonassi, L. Vacca (Rome, Italy)

    Objective: To characterize early morning OFF problems in consecutive PD patients attending a routine clinical appointment. Background: In PD patients with motor fluctuations, total daily…
  • 2017 International Congress

    Programming of deep brain stimulators in Parkinson’s disease with early motor complications (EARLYSTIM-study)

    K. Knudsen, J.-L. Houeto, P. Krack, J. Rau, C. Schade-Brittinger, A. Schnitzler, W.M.M. Schuepbach, L. Timmermann, L. Tonder, G. Deuschl (Kiel, Germany)

    Objective: Recently the EARLYSTIM study showed the superior effect of subthalamic stimulation to best medical treatment in Parkinson`s disease with early motor complications.  Background: EARLYSTIM…
  • 2017 International Congress

    Manual and Verbal guidance during the balance training based in virtual reality is essential for therapeutic results in people with Parkinson’s disease: a randomized clinical trial

    M.E. Pimentel Piemonte, A. Falconi, M. D"Alencar, E. Okamoto (Sao Paulo, Brazil)

    Objective: To compare the effects of balance training in Virtual Reality (VR) supported  by manual and verbal guidance (MVG) versus an identical training in absence…
  • 2017 International Congress

    The effect of dance and Nordic Walking on balance, gait and motor function in Parkinson’s disease

    J. Stożek, M. Rudzińska, I. Staszczak-Gawełda, A. Stenwak, K. Świątek, S. Podsiadło, U. Pustułka-Piwnik, A. Szczudlik (Krakow, Poland)

    Objective: To present two rehabilitation programs based on dance and Nordic Walking (NW) for patients with Parkinson’s disease (PD) and their effects. Background: Parkinson’s disease…
  • 2017 International Congress

    Interactions between amyloid-β and microglial activation in Parkinson’s disease

    C. Ghadery, Y. Koshimori, J. Kim, S. Coakeley, M. Harris, L. Christopher, P. Rusjan, A. Lang, S. Houle, A. Strafella (Toronto, ON, Canada)

    Objective: To evaluate the relationship between microglial activation and amyloid-β deposition in the brain using positron emission tomography (PET) in Parkinson’s disease (PD) with normal…
  • 2017 International Congress

    Beta oscillatory changes during practice and retention of motor skills in healthy subjects and patients with PD

    A. Nelson (NY, USA)

    Objective: The objective is to define the relationship between increase in beta oscillatory changes with practice and retention of motor skills in normal healthy subject…
  • 2017 International Congress

    Associations of DAT SPECT and TCS with prodromal features of Parkinson’s disease: results in PREDICT-PD participants

    A. Noyce, J. Dickson, J. Bestwick, I. Isaias, M. Politis, G. Giovannoni, T. Warner, A. Lees, A. Schrag (London, United Kingdom)

    Objective: To examine whether changes on dopamine reuptake transporter (DAT) SPECT and transcranial sonography (TCS) correlated with Parkinson’s disease (PD) risk scores and other prodromal…
  • 2017 International Congress

    Grey matter abnormalities associated with early cognitive decline in Parkinson’s disease

    A. Moonen, R. Lopes, A. Leentjens, A. Duits, K. Dujardin (Maastricht, Netherlands)

    Objective: To identify patterns of grey matter (GM) abnormalities in patients with Parkinson's disease (PD) with different cognitive profiles.  Background: Cognitive symptoms occur already in…
  • 2017 International Congress

    Brain PET metabolic substrate of Impulse Control Disorders in Parkinson’s Disease

    E. Robin, A. Verger, F. Fluchere, T. Witjas, J.P. Azulay, E. Guedj, A. Eusebio (Marseille, France)

    Objective: The aim of this study was to describe the cerebral metabolic PET substrate and related connectivity changes in Parkinson's disease patients with impulse control…
  • 2017 International Congress

    Substantia nigra area evaluated by neuromelanin-sensitive MRI as an imaging biomarker of disease progression in Parkinson’s disease

    M. Fabbri, S. Reimão, M. Carbalho, R. Nunes, D. Abreu, L. Guedes, R. Bouça, P. Lobo, C. Godinho, M. Coelho, N. Gonçalves, M. Rosa, A. Antonini, J. Ferreira (Lisbon, Portugal)

    Objective: to investigate the pattern of substantia nigra - neuromelanin (SN-NM) area loss and contrast ratio (CR) intensity changes in late-stage Parkinson’s disease (LSPD) patients,…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley